Interim report
Page 1
Medi Assist August 08 , 2026 To , Listing Department National Stock Exchange of India Limited Exchange Plaza Bandra - Kurla Complex , Bandra ( East ) Mumbai - 400 051 Symbol : MEDIASSIST Dear Sir / Madam , Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai - 400 001 Scrip Code : 544088 Subject : Outcome of the Board Meeting - August 08 , 2026 The Board of Directors of Medi Assist Healthcare Services Limited ( the ' Company ' ) in their meeting held today i.e. , August 08 , 2026 , have inter - alia , approved the following : 1 ) Unaudited Financial Results ( Standalone and Consolidated ) for the quarter ended June 30 , 2026 Approved unaudited Financial Results ( Standalone and Consolidated ) of the Company for the quarter ended June 30 , 2026 . Copy of the unaudited Financial Results ( Standalone and Consolidated ) for the quarter ended June 30 , 2026 along with Limited Review Report issued by the Statutory Auditors of the Company are enclosed herewith . 2 ) Intimation of Annual General Meeting and Record Date for the purpose of payment of final dividend for the financial year 2025-26 The 26th Annual General Meeting ( ' AGM ' ) of the Company shall be held on Thursday , September 24 , 2026 at 10:30 AM ( IST ) through Video Conferencing / Other Audio - Visual Means in compliance with applicable circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India . The Board of Directors has fixed Friday , September 11 , 2026 as the Record Date for the purpose of determining the shareholders eligible to receive final dividend of Rs . 2 / - per equity share on the face value of Rs . 5 / - each for the financial year 2025-26 in terms of Regulation 42 of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations , 2015 ( ' SEBI Listing Regulations ' ) . Dividend shall be paid , subject to deduction of tax at source , within 30 days from the date of shareholders ' approval at the ensuing AGM of the Company . Medi Assist Healthcare Services Limited CIN L74900MH2000PLC437885 Registered Office : AARPEE Chambers , SSRP Building , 7th Floor , Andheri Kurla Road , Marol Co - operative Industrial Estate Road Gamdevi , Marol , Andheri East , Marol Bazar , Mumbai - 400 059 , Maharashtra Phone : + 91-22-6259 6797 Corporate Office Tower " D " , 4th Floor , IBC Knowledge Park , 4/1 , Bannerghatta Road , Bengaluru - 560 029 , Karnataka Phone : + 91-80-6919 0000 Email : ask@mediassist.in Website : www.mediassist.in
Page 2
3) Appointment of Mr. Gaurav Bhatnagar as Senior Managerial Personnel in line with SEBI Listing Regulations Based on the recommendation of Nomination & Remuneration Committee, the Board of Directors of the Company have approved designation of Mr. Gaurav Bhatnagar as Senior Managerial Personnel of the Company effective August 08, 2026. He has joined Medi Assist Insurance TPA Private Limited, a subsidiary of the Company as Chief TPA Officer. Disclosure under Regulation 30 of the SEBI Listing Regulations for the said matter, as applicable, is being filed separately. 4) Change in designation of Dr. Vikram Jit Singh Chhatwal from Whole-Time Director to Non-Executive, Non-Independent Director of the Company The Board of Directors of the Company have considered separation of the roles of Chairman and executive management to better align the Company’s governance framework, Board leadership and succession planning. In light of the foregoing, Dr. Vikram Jit Singh Chhatwal (DIN: 01606329) has proposed to demit the office of Whole-Time Director, and to continue on the Board as a Non-Executive, Non-Independent Director and Chairman, liable to retire by rotation, with effect from the close of business hours of August 08, 2026. Consequently, he shall cease to be a Key Managerial Personnel of the Company with effect from the said date. Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors have approved the aforesaid change in designation, subject to approval of the members of the Company and such other approvals as may be required. Disclosure under Regulation 30 of the SEBI Listing Regulations for the said matter, as applicable, is being filed separately. The Board Meeting commenced at 1.45 p.m. (IST) and concluded at 3.00 p.m. (IST). The trading window for dealing in shares of the Company is closed from July 01, 2026 till August 10, 2026. This outcome shall also be made available on the Company’s website at www.mediassist.in You are requested to take the same on record. Yours faithfully, For Medi Assist Healthcare Services Limited Rashmi B V Company Secretary & Compliance Officer ICSI Membership No: A38729 Encl.: Unaudited financial results along with Limited Review Report
Page 3
. SV Tower, No. 27, Floor 4 M S K A & ASSOC]ateS LLP 80 Feet Road, 6th Block, Koramangala (Formerly known as M S K A & Associates) ARSI 6000 MDA Chartered Accountants Independent Auditor’s Review Report on standalone unaudited financial results of Medi Assist Healthcare Services Limited for the quarter pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. To The Board of Directors of Medi Assist Healthcare Services Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results of Medi Assist Healthcare Services Limited (hereinafter referred to as ‘the Company’) for the quarter ended June 30, 2026 (‘the Statement’) attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Regulations’). 2. This Statement, which is the responsibility of the Company’s Management and has been approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ‘Interim Financial Reporting’, prescribed under Section 133 of the Companies Act, 2013 (‘the Act’) read with relevant rules issued thereunder (‘Ind AS 34’) and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Page 1 of 2 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 | LLPIN: ACT-3789 Ahmedabad | Chandigarh | Chennai | Coimbatore | Goa | Gurugram | Hyderabad | HKochi | Kolkata | Mumbai | Pune www.mska.in
Page 4
MSKA & Associates LLP (Formerly known as M S K A & Associates) Chartered Accountants 5. Emphasis of matter We draw attention to Note 7 to the accompanying Statement which describes that search and seizure operation was carried out by the Directorate of Enforcement at certain offices of a wholly owned subsidiary and the management's assessment thereof about the consequent impact on the Statement. Our conclusion is not modified in respect of this matter. For M S K A & Associates LLP (Formerly known as M S K A & Associates) Chartered Accountants ICAI Firm Registration No.105047W/W101187 S RE Pankaj S Bhauwala Partner Membership No.: 233552 UDIN: 26233552IKWBNS5773 Place: Bengaluru Date: August 08, 2026 Page 2 of 2 s Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 | LLPIN: ACT-3789 Ahmedabad | Chandigarh | Chennai | Coimbatore | Goa | Gurugram | Hyderabad | Kochi | Kolkata | Mumbai | Pune www.mska.in
Page 5
Medi Assist Healthcare Services Limited Corporate Identity Number; L74900MH2000PLC437885 Registered office: AARPEE Chambers, SSRP Building, 7th Floor, Marol Co-operative Industrial Estate Road. Gamdevi, Marol, Andheri East, Mumbai - 400059, India. Telephone .: 91- 8069190000, E-mail: ask@mediassist.in: website: www.mediassist.in Statement of unaudited standalone financial results for the quarter ended 30 June 2026 (Rs. in millions unless otherwise stated) Quarter ended Year ended Sr. No. Particulars 30 June 2026 31 March 2026 30 June 2025 31 March 2026 Unaudited Audited Unaudited Audited (refer note 3) (refer note 4) 1 Income Revenue from operations 589.84 635.63 437.04 2.254.55 Other income 70.28 51.48 2361 146.31 Total income 660.12 687.11 460.65 2,400.86 2 Expenses Employee benefits expense 132.00 119.10 69.59 426.20 Finance costs 11.12 4577 8.69 65.26 Depreciation and amortisation expenses 48.81 51.32 50.69 203.22 Other expenses 291.20 276.93 223.15 1.018.00 Total expenses 483.13 493.12 352.12 1,712.68 3 Profit before exceptional item and tax (1-2) 176.99 193.99 108.53 688.18 4 Exceptional item (refer note 10) - - = 0.52 5 Profit before tax for the period/ year (3-4) 176.99 193.99 108.53 687.66 6 Income tax expense: Current tax 31.78 56.76 26.24 187.88 Deferred tax expense /(credit) 13.69 (7.74) 2.09 (20.08) Total income tax expense 45.47 49.02 28.33 167.80 7 Profit for the period/ year (5-6) 131.52 144,97 80.20 519.86 8 Other comprehensive income/(loss) Items that will not be reclassified subsequently to statement of prolilb and loss Re-measurement of gains/(losses) on defined benefit plans (1.18) (2.45) 0.07 1.45 !:aar value changes in equity instruments through other comprehensive 637 4.78) 474 (4.61) income Income tax relating to items that will not be reclassified to statement of profit 0.68 i ©.71) ©.71) and loss Total other comprehensive income/(loss) for the period/ year, net of tax 5.87 (7.23) 4.10 (3.87) LY 9 Total comprehensive income for the period/ year (7+8) 137.39 137.74 84.30 515.99 10 Paid up equity share capital (face value of Rs. 5 each) 373.51 373.05 352.69 373.05 11 Other equity 4,520.83 12 Earnings per equity share (face value of Rs. 5 each) (not annualised except for the year ended 31 March 2026) Basic (Rs) 1.76 1.95 1.14 7.18 Diluted (Rs) 1.76 1.95 1.13 7.18 (Page 1 of 3)
Page 6
Notes to statement of unaudited standalone financial results for the quarter ended 30 June 2026 In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the above unaudited standalone financial results of Medi Assist Healthcare Services Limited ("the Company") have been reviewed and recommended by the Audit Committee and approved by the Board of Directors, at their respective meetings held on 08 August 2026. These unaudited standalone financial results have been subjected to limited review by the Statutory auditors of the Company and they have issued an unmodified review report on these unaudited standalone financial results. The above unaudited standalone financial results for the quarter ended 30 June 2026 have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015, as amended, ("Ind AS") prescribed under section 133 of Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable. The figures for the quarter ended 31 March 2026 are the balancing figures between the audited figures for the year ended 31 March 2026 and reviewed published ligures of nine month ended 31 December 2025. The figures for the year ended 31 March 2026 have been exiracted from the general purpose standalone financial statements of the Company for the year ended 31 March 2026 which were audited by the Statutory auditors of the Company, The Company is engaged in the business of providing health management services which it is determined to be the only reportable segment in terms of’ Ind AS 108 "Operating Segments". On 26 August 2024, Medi Assist Insurance TPA Private Limited ("Transferee Company"/"MAITPA"), the wholly owned subsidiary of the Company had entered into Share Purchase Agreement ("SPA"™) with Paramount Health Services and Insurance TPA Private Limited ("Transferor Company"/"Paramount TPA") and the Shareholders of the Transferor Company, to purchase 100% equity shares of Transferor Company at a total enterprise value of Rs. 3,118.00 million (Rupees three thousand one hundred ¢ighteen million only) (subject to closing adjustments) which is subject to fulfilment of conditions precedent as defined in the SPA. Regulatory approval from Insurance Regulatory and Development Authority of India (IRDAI) was received on 13 May 2025. On 01 July 2025, the Company had completed acquisition of 100% equity stake in Paramount TPA upon payment of the purchase consideration of Rs. 4,124.40 million after closing adjustments as per SPA, and the share transfer was duly executed. Consequently, Paramount TPA became a wholly- owned subsidiary of MAITPA and step-down subsidiary of the Companly. During the previous year ended 31 March 2026, on 04 April 2023, the Enforcement Directorate (the “ED™) conducted a search and seizure operation at certain offices of MAITPA, located in Ranchi, Jharkhand. MAITPA is one of the third-party administrators (TPAs) engaged in administering the Ayushman Bharat-linked health scheme in the state of Jharkhand. MAITPA has fully co-operated with the officials during the proceedings and responded to the clarifications and details sought by them. As on the date of issuance of these standalone financial results, MAITPA has not received any communication from the ED regarding the outcome of the search, The Management, after considering all available records and facts known to it, is of the view that there is no adverse impact on the Company, and no adjustment is required in these standalone financial results for the quarter ended 30 June 2026 in this regard. During the year ended 31 March 2026, Paramount TPA, a material step-down subsidiary of the Company, experienced a cyber-security incident that impacted certain systems and services. The incident was fully contained at the Paramount TPA level and did not affect the Company or any of its other subsidiaries. The Company had reported to and intimated the relevant authorities including the stock exchanges of this event. Pursuant to the above, Paramount TPA. undertook certain security and business continuity measures including engaging external experts to support system restoration, cyber-forensic activities, elc. Additionally, Paramount TPA had lodged an insurance claim under its cyber-insurance policy for recovery of the eligible costs incurred towards the above incident. The Management, after considering all available information believes no additional adjustments are considered necessary in the standalone financial results for the quarter ended 30 June 2026. The Board of Directors of the Company at its meeting held on 07 August 2025 approved the issuance of equity shares by way of preferential allotment and constitution of Fund Raising Committee. The same was subsequently approved by the Shareholders of the Company at the Exiraordinary General Meeting of the Company (‘EGM") held on 04 September 2025. Pursuant to the above approvals, on 10 October 2025, Fund Raise Committee allotted 37,01,000 (Thirty Seven Lakh and One Thousand) fully paid-up equity shares of face value Rs. 5 each at a price of Rs. 535 per share (including a share premium of Rs. 530 per share), for an aggregate consideration of Rs. 1,98,00,35,000 (Rupees One Hundred Ninety-Eight Crore and Thirty-Five Thousand only). The equity shares were allotted on a private placement basis to identified investors as per the details set forth below: Name of Allottees Category Number of shares|Price at which equity shares|Consideration issued are issued (including a share|received as on the premium of Rs. 530 per share) |date of allotment (Rs. Millions) Massachusetts Institute Technology Non- promoter 28.,90,830 535 1,546.59 238 Plan Associates LLC Non- promoter 8,10,170 533 433.44 Total 37,01,000 1,980.03 The net proceeds from the above were utilized for the purposes as stated in the Offer documents other than Rs. 448.80 million which is lying unspent as of 30 June 2026. In accordance with Ind AS 32, the costs that are directly attributable to the above transactions, have been adjusted in equity. (Page 2 of 3)
Page 7
Notes to statement of unaudited standalone financial results for the quarter ended 30 June 2026 10 Effective 21 November, 2023, the Government of India consolidated 29 existing labour regulations into four Labour codes. namely, The Code on Wages, 2019, The Industrial Relations Code, 2020, The Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes'. The New Labour Codes has resulted in material increase in provision for employee benefits on account of recognition of past service costs, Based on the requirements of New Labour Codes, internal management assessment, actuary report and the best information available, accounting standards and in line with ICAI guidance, the Company had assessed and accounted the estimated incremental impact of Rs. 0.32 million as Exceptional Item in the standalone financial results for the year ended 31 March 2026. 11 During the year ended 31 March 2026, MAITPA and Paramount TPA in their respective meeting(s) held on 29 December 2025, had considered and approved the Scheme of Amalgamation/merger of Paramount TPA with MAITPA under the provisions of Section 233 of the Companies Act, 2013 and the rules made thereunder. Subsequently, the Board of Directors of MAITPA and Paramount TPA, at the respective meetings held on 06 February 2026, have approved the withdrawal of the aforementioned merger, and in place of the above, noted and approved the transfer of the TPA business of Paramount TPA w.e.f 01 February 2026, to MAITPA, by way of a Business Transfer Agreement (‘BTA’), the BTA constituted transfer of all assets and liabilities relating to the TPA business except for certain balances including treasury assets by way of slump transfer for nil consideration. Further the Company, has considered and approved a Scheme of Merger by Absorption of Paramount TPA (“Transferor Company™) with the Company (“Transferee Company”) and their respective shareholders and creditors, pursuant to the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (“Scheme™), subject to receipt of requisite statutory, regulatory and other approvals, as applicable. Subsequent to the quarter ended 30 June 2026, The Insurance Regulatory and Development Authority of India (IRDAI) has sought certainf clarifications in relation to the aforesaid matter, to which MAITPA and Paramount TPA have submitted a joint response, 12 During the year ended 31 March 2026, the Board of Directors of International Healthcare Management Services Private Limited, wholly owned subsidiary, ("[HMS"/"Transferor Company") and Mayfair Consultancy Services India Private Limited, wholly owned subsidiary, ("MCSI"/"Transferce Company") approved, at their respective meetings held on 06 February 2026, a Scheme of Amalgamation/merger of [HMS with MCSI under Section 233 of the Companies Act, 2013, with an appointed date of 01 April 2025. The Scheme was filed with the Regional Director ("RD"), who forwarded the application to the Hon'ble National Company Law Tribunal, Bengaluru Bench (“Hon'ble NCLT™), vide order dated 19 May 2026, under Section 233(5) for its consideration. During the quarter ended 30 June 2026, the Hon'ble NCLT Registry sought additional documents/information, which the Companies have furnished. The matter is pending before the Hon'ble NCLT for issuance of notice and further directions. 13 During the quarter, in accordance with the terms of the Sharcholder's Agreement ("SHA™), the Company exercised its contractual option to acquire an additional 31.75% equity stake in Mayfair We Care Limited, which was approved by the Board of Directors vide its meeting held on 24 June 2026. In connection with the proposed acquisition, the Company paid an advance of Rs. 47.17 million on 30 June 2026 and a further sum of Rs. 28.51 million on 01 July 2026 and completed the acquisition of aforementioned stake effective 01 July 2026. 14 Previous period / year figures have been regrouped / rearranged / reclassified wherever necessary to make it comparable. Place: Bengaluru For and on behalf of the Board of Directors Date: 08 August 2026 Medi Assist Healthcare Services Limited Satish Gidugu CEO and Whole Time Director DIN: 06643677 (Page 3 of 3) Initialed For Identification Purposes Only
Page 8
. SV Tower, No. 27, Floor 4 MSKA & Associates LLP 0 Foet Roadt 6ok Mok Pl (Formerly known as M S K A & Associates) Bengaluru 360090, MOIA Chartered Accountants Independent Auditor’s Review Report on consolidated unaudited financial results of Medi Assist Healthcare Services Limited for the quarter pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Medi Assist Healthcare Services Limited 1. We have reviewed the accompanying Statement of consolidated unaudited financial results of Medi Assist Healthcare Limited (hereinafter referred to as ‘the Holding Company’), its subsidiaries, (the Holding Company and its subsidiaries together referred to as the ‘Group’) for the quarter ended June 30, 2026 (‘the Statement’) attached herewith, being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Regulations’). 2. This Statement, which is the responsibility of the Holding Company’s Management and approved by the Holding Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ‘Interim Financial Reporting’ prescribed under Section 133 of the Companies Act, 2013 (‘the Act’) read with relevant rules issued thereunder (‘Ind AS 34’) and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review, 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, ‘Review of Interim Financial Information Performed by the Independent Auditor of the Entity’ issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the Securities and Exchange Board of India under Regulation 33 (8) of the Regulations, to the extent applicable. Page 1 of 3 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: =91 22 6974 0200 | LLPIN: ACT-3789 Ahmedabad | Chandigarh | Chennai | Coimbatore | Goa | Gurugram | Hyderabad | Kochi | Kolkata | Mumbai | Pune www.mska.in
Page 9
MSKA & Associates LLP (Formerly known as M S K A & Associates) Chartered Accountants 4. This Statement includes the results of the Holding Company and the following entities: Sr. No Name of the Entity Relationship with the Holding Company 1 Medi Assist Insurance TPA Private Limited Wholly owned subsidiary 2 International Healthcare Management Services Private | Wholly owned subsidiary Limited 3 Mayfair Consultancy Services India Private Limited Wholly owned subsidiary 4 Mayfair We Care Limited Subsidiary 5 Mayfair We Care Philippines Inc Stepdown subsidiary 6 Mayfair We Care Pte Limited Stepdown subsidiary 7 Paramount Health Services a Insurance TPA Private | Stepdown subsidiary Limited 5. Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the consideration of the review reports of the other auditors referred to in paragraph 7, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 6. Emphasis of Matter We draw attention to Note 8 to the accompanying Statement which describes that search and seizure operation was carried out by the Directorate of Enforcement at certain offices of a wholly owned subsidiary and the management's assessment thereof about the consequent impact on the Statement. Our conclusion is not modified in respect of this matter. Page 2 of 3 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 | LLPIN: ACT-3789 Ahmedabad | Chandigarh | Chennai | Coimbatore | Goa | Gurugram | Hyderabad | Kochi | Kolkata | Mumbai | Pune www.mska.in
Page 10
MSK A & Associates LLP (Formerly known as M S K A & Associates) Chartered Accountants 7. We did not review the interim financial information of one subsidiary and three step subsidiaries included in the Statement, whose interim financial information reflect total revenues of Rs. 100.67 million, total net profit after tax of Rs. 40.13 million and total comprehensive income of Rs. 42.40 million for the quarter ended June 30, 2026 respectively, as considered in the Statement. These interim financial information have been reviewed by other auditors whose reports have been furnished to us by the Management and our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries, is based solely on the report of the other auditors and the procedures performed by us as stated in paragraph 3 above. Our conclusion is not modified in respect of the above matter with respect to our reliance on the work done by and report of the other auditors. For MS K A & Associates LLP (Formerly known as M S K A & Associates) Chartered Accountants ICAIl Firm Registration No.105047W/W101187 4 ALy o Pankaj S Bhauwala Bangalore | Partner hef/ 4 Membership No.: 233552 UDIN: 26233552NJJGKA5774 Place: Bengaluru Date: August 08, 2026 Page 3 of 3 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 | LLPIN: ACT-3789 Ahmedabad | Chandigarh | Chennai | Coimbatore | Goa | Gurugram | Hyderabad | Kochi | Kolkata | Mumbai | Pune www.mska.in
Page 11
Medi Assist Healthcare Services Limited Corporate Identity Number: L74900MH2000PLC437885 Registered office: AARPEE Chambers, SSRP Building, 7th Floor, Marol Co-operative Industrial Estate Road, Gamdevi, Marol, Andheri East, Mumbai - 400059, India. Telephone .: 91- 8069190000, E-mail: ask@mediassist.in; website; www.mediassist.in Statement of unaudited consolidated financial results for the quarter ended 30 June 2026 (Rs. in millions unless otherwise stated) Quarter ended Year ended Sr. , 30 June 2026 31 March 2026 30 June 2025 | 31 March 2026 No Particulars y " Audited : . Audited j i Haudiced (refer note 3) e (refer note 4) 1 |Income Revenue from operations 2.365.19 2,419.86 1,905.58 9,047.67 Other income 104.97 27.33 72.86 196.36 Total income 2.470.16 2,447.19 1,978.44 9,244.03 2 |Expenses Employee benefits expense 1,032.60 1,053.84 798.64 3,940.72 Finance costs 3 17.59 21.37 46.74 22571 Depreciation and amortisation expenses 218.47 209.51 141.12 771.25 Other expenses 852.43 883.43 686.82 3,360.88 Total expenses 2,121.09 2,168.15 1,673.32 8,298.56 3 |Profit before exceptional items and tax (1-2) 349.07 279.04 305.12 945.47 4 |Exceptional items (refer note 10) - - - 141.95 5 |Profit before tax for the period/ year (3-4) 349.07 279.04 305.12 803.52 | 6 |Income tax expense: Current tax 32.92 49.31 102.72 318.74 Adjustment for current tax relating to earlier years - - - 12.81 Deferred tax expense/ (credit) (refer note 11) 40.18 (315.04) {23.91) (421.14) Total income tax expense 73.10 (265.73) 78.81 (89.59) 7 |Profit for the period/ year (5-6) 275.97 544.77 226.31 893.11 8 |Other comprehensive income/(loss) Items that will not be reclassified subsequently to statement of profit and loss Re-measurement of gains/(losses) on defined benefit plans (0.98) (38.22) (9.08) (9.43) Fair value changes in equity instruments through other comprehensive income 6.89 1.52 5.10 (0.12) :::Some 1ax relating to items that will not be reclassified to statement of profit and 0.85 110 159 159 Item that will be reclassified to statement of profit and loss in subsequent periods Exchange differences on translation of foreign operations 4,20 11.68 14.21 34.69 Total other comprehensive income/(loss) for the period/ year, net of tax 10.96 (23.92) 11.82 26.73 9 |Total comprehensive income for the period/ year (7+8) 286.93 520.85 238.13 919.84 {Page 1 of 5)
Page 12
Medi Assist Healthcare Services Limited Corporate Identity Number: L74900MH2000PLC437885 Registered office: AARPEE Chambers, SSRP Building, 7th Floor, Marol Co-operative Industrial Estate Road, Gamdevi, Marol, Andheri East, Mumbai - 400059, India. Telephone _: 91- 8069190000, E-mail: ask/@mediassist.in; website: www.mediassist.in Statement of unaudited consolidated financial results for the quarter ended 30 June 2026 (Rs. in millions unless otherwise stated) Quarter ended Year ended Sr. < 30 June 2026 31 March 2026 30 June 2025 | 31 March 2026 No Particulars . . Audited . . Audited Unaudited (refer note 3) Unaudited fefirnoted) 10 |Profit for the period/ year attributable to: Owners of the Company 276.84 534.44 223.97 878.89 Non-controlling interest (0.87)] . 10.33 234 14.22 Profit for the period/ year 275.97 544.77 226.31 893.11 11 |Other comprehensive income/ (loss) for the period/ year attributable to: Owners of the Company 928 (28.59) 6.13 12.85 Non-controlling interest 1.68 4.67 5.69 13.88 Other comprehensive income/ (loss) for the period/ year 10.96 (23.92) 11.82 26.73 12 [Total comprehensive income for the period/ year attributable to: Owners of the Company 286.12 505.85 230.11 891.75 Non-controlling interest 0.81 15.00 8.02 28.09 Total comprehensive income for the period/ year 286.93 520.85 238.13 919.84 13 |Paid up equity share capital (face value of Rs. 5 each) 373.51 373.05 352.69 373.05 14 [Other equity 8,015.98 15 |Earnings per equity share (face value of Rs. 5 each) (not annualised except for the year ended 31 March 2026) ' Basic (Rs) 371 7.33 3.18 12.14 Diluted (Rs) 37 7.33 3.16 12.14 (Page 2 of 5)
Page 13
Notes to statement of unaudited consolidated financial results for the quarter ended 30 June 2026 In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations; 2015, as amended, the above unaudited consolidated financial results of Medi Assist Healthcare Services Limited ("the Holding Company” or "the Company"), ifs subsidiaries (the Holding Company along with subsidiaries together referred 1o as "the Group") have been reviewed and recommended by the Audit Committee and approved by the Board of Directors, at their respective meetings held on 08 August 2026. These unaudited consolidated financial results have been subjected to limited review by the Statutory auditors of the Company and they have issued an unmodified review report on these unaudited consolidated financial results. The above unaudited consolidated financial results for the quarter ended 30 June 2026 have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015, as amended, ("Ind AS") prescribed under section 133 of the Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable. The figures for the quarter ended 31 March 2026 are the balancing figures between the audited figures for the year ended 31 March 2026 and reviewed published figures of nine month ended 31 December 2025, The figures for the year ended 31 March 2026 have been extracted from the general purpose consolidated financial statements of the Company for the year ended 31 March 2026 which were audited by the Statutory auditors of the Company. The Company is engaged in the business of providing health management services which it is determined to be the only reportable segment in terms of Ind AS 108 " Operating Segments”. On 26 August 2024, Medi Assist [nsurance TPA Private Limited ("Transferee Company"/"MAITPA"), the wholly owned subsidiary of the Company had entered into Share Purchase Agreement ("SPA") with Paramount Health Services and Insurance TPA Private Limited ("Transferor Company"/"Paramount TPA") and the Shareholders of the Transferor Company, to purchase 100% equity shares of Transferor Company at a total enterprise value of Rs. 3,118.00 million (Rupees three thousand one hundred eighteen million only) (subject to closing adjustments) which is subject to fulfilment of conditions precedent as defined in the SPA. Regulatory approval from [nsurance Regulatory and Development Authority of India (IRDAI) was received on 13 May 2025, On 01 July 2025, the Company had completed acquisition of 100% equity stake in Paramount TPA upon payment of the purchase consideration of Rs. 4,124.40 million after closing adjustments as per SPA, and the share transfer was duly executed. Consequently, Paramount TPA became a wholly-owned subsidiary of MAITPA and step-down subsidiary of the Company. This statement includes the results of the Holding Company and the following entities: Sl |Name of the Entity Relationship with the Holding Company 1 |Medi Assist Insurance TPA Private Limited Wholly owned subsidiary 2 |International Healthcare Management Services Private Limited (refer to note 12) Wholly owned subsidiary 3 |Mayfair Consultancy Services India Private Limited (refer to note 12) Wholly owned subsidiary 4 |Mayfair We Care Limited {refer to note 13) Subsidiary 5 |Mayfair We Care Philippines Inc Stepdown subsidiary 6 |Mayfair We Care Pte Limited Stepdown subsidiary 7 |Paramount Health Services and Insurance TPA Private Limited Stepdown subsidiary During the previous year ended 31 March 2026, on 04 April 2025, the Enforcement Directorate (the “ED”) conducted a search and seizure operation at certain offices of MAITPA, located in Ranchi, Jharkhand. MAITPA is one of the third-party administrators (TPAs) engaged in administering the Ayushman Bharat-linked health scheme in the state of Jharkhand. MAITPA has fully co-operated with the officials during the proceedings and responded to the clarifications and details sought by them. As on the date of issuance of these consolidated financial results, MAITPA has not received any communication from the ED regarding the outcome of the search, The Management, after considering all available records and facts known to it, is of the view that there is no adverse impact on the Group, and no adjustment is required in these consolidated financial results for the quarter ended 30 June 2026 in this regard. The Board of Directors of the Company at its meeting held on 07 August 2025 approved the issuance of equity shares by way of preferential allotment and constitution of Fund Raising Committee. The same was subsequently approved by the Shareholders of the Company at the Extraordinary General Meeting of the Company (‘EGM") held on 04 September 2025. Pursuant to the above approvals, on 10 October 2025, Fund Raise Committee allotted 37,01,000 (Thirty Seven Lakh and One Thousand) fully paid-up equity shares of face value Rs. 5 each at a price of Rs. 535 per share (including a share premium of Rs. 530 per share), for an aggregate consideration of Rs. 1,98,00,35,000 (Rupees One Hundred Ninety-Eight Crore and Thirty-Five Thousand only). The equity shares were allotted on a private placement basis to identified investors as per the details set forth below: Name of Alloftees Category Number of shares|Price at which equity|Consideration issued shares are issued|received as on the (including a share{date of allotment premium of Rs. 530{(Rs. million) per share) Massachusetts Institute of Technology Non- promoter 28.,90,830 535 1,546.59 238 Plan Associates LLC Non- promoter 8,10,170 535 433.44 Total 37,01,000 1,980.03 The net proceeds from the above were utilized for the purposes as stated in the Offer documents other than Rs. 448.80 million which is lying unspent as of 30 June 2026. In accordance with Ind AS 32, the costs that are directly attributable to the above transactions, have been adjusted in equity. (Page 3 ol 5)
Page 14
Notes to statement of unaudited consolidated financial results for the quarter ended 30 June 2026 10 (a) (b) () Exceptional items During the year ended 31 March 2026, Paramount TPA, a material step-down subsidiary of the Company, experienced a cyber-security incident that impacted certain systems and services. The incident was fully contained at the Paramount TPA level and did not affect the Company or any of its other subsidiaries. The Company had reported to and intimated the relevant authorities including the stock exchanges of this event. Pursuant to the above, Paramount TPA undertook certain security and business continuity measures including engaging external experts (0 support system restoration, cyber-forensic activities, etc. Towards these measures, Paramount TPA incurred costs amounting to Rs. 37.68 million upto 31 March 2026 and these have been presented as an exceptional item in the consolidated financial results for the year ended 31 March 2026. Additionally, Paramount TPA has lodged an insurance claim under its cyber-insurance policy for recovery of the eligible costs incurred towards the above incident. The Management, after considering all available information believes no additional adjustments are considered necessary in the consolidated financial results for the quarter ended 30 June 2026. Effective 21 November, 2025, the Government of India consolidated 29 existing labour regulations into four Labour codes, namely, The Code on Wages, 2019, The Industrial Relations Code. 2020, The Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes’. The New Labour Codes has resulted in material increase in provision for employee benefits on account of recognition of past service costs. Based on the requirements of New Labour Codes, internal management assessment, actuary report and the best information available, accounting standards and in line with ICAI guidance, the Company had assessed and accounted the estimated incremental impact of Rs. 33.27 million as Exceptional Item in the consolidated financial results for the year ended 31 March 2026. During the year ended 31 March 2026, pursuant to a claim received by MAITPA from its customer (insurance company), towards claims disallowed for claims alleged to be processed by MAITPA. In line with the past practices, MAITPA made on account payments to the insurance company pending review and reconciliation of these claims aggregating to Rs. 71.00 million. Further, MAITPA had performed an internal evaluation and assessment, basis which management is of the view that there will not be any adjustments towards recoveries for the aforementioned advances paid and are eligible for a full recovery of advance paid to the customer, however as . the discussion with the customer are ongoing and the Company is yet to receive adequate and complete information from the customer to conclude the settlement, on a prudent basis the Company has made a full provision amounting to Rs. 71.00 million towards the net advance paid and disclosed this as an exceptional item. The Company has initiated steps to recover the funds and after considering all available information believes no additional adjustments are considered necessary in the consolidatéd financial results for the quarter ended 30 June 2026. During the year ended 31 March 2026, MAITPA and Paramount TPA in the meetings of their respective Board of Directors held on 29 December 2025, had considered and approved the Scheme of Amalgamation/merger of Paramount TPA with MAITPA under the provisions of Section 233 of the Companies Act, 2013 and the rules made thereunder. Subsequently, the Board of Directors of MAITPA and Paramount TPA, at the respective meetings held on 06 February 2026, had approved the withdrawal of the aforementioned merger, and in place of the above, noted and approved the transfer of the TPA business of Paramount TPA w.e.f 01 February 2026, to MAITPA, by way of a Business Transfer Agreement ('BTA’), the BTA constituted transfer of all assets and liabilities relating to the TPA business except for certain balances including treasury assets by way of slump transfer for nil consideration. Consequently, the appropriate adjustments including relating to adjustment of deferred tax balances amounting to Rs. 328.68 million have been appropriately considered in these consolidated financial results. Further the Board of Directors of MAITPA and Paramount TPA, at the their respective meetings held on 06 February 2026, had considered and approved a Scheme of Merger by Absorption of Paramount TPA (“Transferor Company™) with the Company (“Transferee Company™) and their respective shareholders and creditors, pursuant to the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ("Scheme™), subject to receipt of requisite statutory, regulatory and other approvals, as applicable. Subsequent to the quarter ended 30 June 2026, The Insurance Regulatory and Development Authority of India (IRDAI) has sought certain clarifications in relation to the aforesaid matter, to which MAITPA and Paramount TPA have submitted a joint response. During the year ended 31 March 2026, the Board of Directors of International Healthcare Management Services Private Limited, wholly owned subsidiary, ("IHMS"/"Transferor Company") and Mayfair Consultancy Services India Private Limited, wholly owned subsidiary, ("MCSI"/"Transferee Company") approved, at their respective meetings held on 06 February 2026, a Scheme of Amalgamation/merger of IHMS with MCSI under Section 233 of the Companies Act, 2013, with an appointed date of 01 April 2025. The Scheme was filed with the Regional Director ("RD"), who forwarded the application to the Hon'ble National Company Law Tribunal, Bengaluru Bench (“Hon'ble NCLT"), vide order dated 19 May 2026, under Section 233(3) for its consideration. During the quarter ended 30 June 2026, the Hon'ble NCLT Registry sought additional documents/information, which the Companies have furnished. The matter is pending before the Hon'ble NCLT for issuance of notice and further directions. (Page 4 of 5)
Page 15
Notes to statement of unaudited consolidated financial results for the quarter ended 30 June 2026 13 During the quarter, in accordance with the terms of the Shareholder's Agreement ("SHA"), the Company exercised its contractual option to acquire an additional 31.75% equity stake in Mayfair We Care Limited, which was approved by the Board of Directors vide its meeting held on 24 June 2026. In connection with the proposed acquisition, the Company paid an advance of Rs. 47.17 million on 30 June 2026 and a further sum of Rs. 28.51 million on 01 July 2026 and completed the acquisition of aforementioned stake effective 01 July 2026. Accordingly, the derivative liability recognised in respect of the non-controlling interest was remeasured as at 30 June 2026, resulting in a gain of Rs. 31.18 million, which has been recognised as Other Income in these results for the quarter ended 30 June 2026. 14 Previous period / year figures have been regrouped / rearranged / reclassified wherever necessary to make it comparable. Place: Bengaluru For and on behalf of the Board of Directors of Date: 08 August 2026 Medi Assist Healthcare Services Limited " Satish Gidugu CEO and Whole Time Director DIN: 06643677 (Page 5 of 5) Initialed For Identification Purposes Only